These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2693076)
1. Efficacy of ethanolamine and polidocanol in the eradication of esophageal varices. A prospective randomized trial. Balanzó J; Sainz S; Espinós JC; Such J; Segura J; Guarner C; Cussó X; Vilardell F Endoscopy; 1989 Nov; 21(6):251-3. PubMed ID: 2693076 [TBL] [Abstract][Full Text] [Related]
2. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669 [TBL] [Abstract][Full Text] [Related]
4. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension. Omar MM; Fakhry SM; Mostafa I J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052 [TBL] [Abstract][Full Text] [Related]
5. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate. Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Svoboda P; Kantorová I; Ochmann J; Kozumplík L; Marsová J Surg Endosc; 1999 Jun; 13(6):580-4. PubMed ID: 10347295 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic sclerotherapy in a rat model of esophageal varices. Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578 [TBL] [Abstract][Full Text] [Related]
8. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Feretis C; Dimopoulos C; Benakis P; Kalliakmanis B; Apostolidis N Endoscopy; 1995 Jun; 27(5):355-7. PubMed ID: 7588348 [TBL] [Abstract][Full Text] [Related]
9. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol. Nishida R; Inoue R; Takimoto Y; Kita T J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514 [TBL] [Abstract][Full Text] [Related]
10. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347 [TBL] [Abstract][Full Text] [Related]
11. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal. Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy. Ravi M; Kate V; Ananthakrishnan N Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957 [TBL] [Abstract][Full Text] [Related]
13. Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding. Zimmer T; Rucktäschel F; Stölzel U; Liehr RM; Schuppan D; Stallmach A; Zeitz M; Weber E; Riecken EO J Hepatol; 1998 Feb; 28(2):292-7. PubMed ID: 9514542 [TBL] [Abstract][Full Text] [Related]
14. Prediction of the recurrence of esophageal varices based on portal vein pressure and oxygen tension in portal and peripheral blood. Obara K; Sakamoto H; Kasukawa R Gastroenterol Jpn; 1991 Dec; 26(6):707-11. PubMed ID: 1765244 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices. Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387 [TBL] [Abstract][Full Text] [Related]
16. Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: a prospective, randomized, controlled trial. Sarin SK; Mishra SP; Sachdev GK; Thorat V; Dalal L; Broor SL Am J Gastroenterol; 1988 May; 83(5):526-30. PubMed ID: 3284336 [TBL] [Abstract][Full Text] [Related]
17. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic sclerotherapy for esophageal varices: a prospective, randomised trial of absolute alcohol versus polidocanol. Atamkuri SP; Bhargava DK; Sharma MP Indian J Gastroenterol; 1988 Apr; 7(2):87-9. PubMed ID: 3360476 [No Abstract] [Full Text] [Related]
19. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial. Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520 [TBL] [Abstract][Full Text] [Related]
20. Trial of sclerosing agents in patients with oesophageal varices. Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]